HighTower Advisors
BSX icon

HighTower Advisors’s Boston Scientific BSX Stock Holding History

HighTower Advisors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-200
Closed -$2K – 3363
2022
Q3 		$2K Buy
+200
New +$8.02K ﹤0.01% 3093

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

HighTower Advisors's BSX Position: Q1 2026 in Review

HighTower Advisors increased its Boston Scientific (BSX) stake by 22% in Q1 2026, buying an estimated $3M and bringing the position to 209,968 shares worth $13.2M. The position accounts for 0.01% of the portfolio, ranked #766.

HighTower Advisors first reported a position in BSX in Q2 2013 and has held it in 45 quarters since. The position peaked at $19.3M in Q2 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • HighTower Advisors held 209,968 shares of Boston Scientific worth $13.2M as of Q1 2026.
  • HighTower Advisors bought 37,473 Boston Scientific shares in Q1 2026, an estimated $3M.
  • Boston Scientific made up 0.01% of HighTower Advisors's portfolio in Q1 2026, its #766 holding.
  • HighTower Advisors first reported a position in Boston Scientific in Q2 2013 and has held it in 45 quarters since.
  • HighTower Advisors's Boston Scientific position peaked at $19.3M in Q2 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on HighTower Advisors's 13F filing for Q1 2026, filed 5 May 2026.